Literature DB >> 31431682

Clustering of risk factors and the risk of new-onset hypertension defined by the 2017 ACC/AHA Hypertension Guideline.

Yuli Huang1,2, Meng Dai3, Zhihui Deng1, Xingfu Huang1, Hanlin Li1, Yujia Bai1, Chuanjie Yan3, Qiong Zhan1, Qingchun Zeng1, Ping Ouyang3, Dingli Xu4.   

Abstract

The 2017 American College of Cardiology (ACC)/American Heart Association (AHA) lowered the diagnostic criteria for hypertension. We aimed to explore whether clustering of multiple risk factors are associated with the risk of new-onset hypertension defined by the 2017 ACC/AHA Hypertension Guideline. Subjects who attended ≥2 annual health examinations without baseline hypertension and cardiovascular disease were included. Hypertension was defined according to the 2017 ACC/AHA Hypertension Guideline. Seven predefined risk factors, including age, resting heart rate, overweight or obesity, dyslipidemia, hyperuricemia, impaired glucose regulation, and a poor estimated glomerular filtration rate, were analyzed. A composite, individual-level, cumulative score incorporating these seven risk factors (no = 0 point; yes = 1 point; total range of 0-7 points) was calculated. The association between the cumulative score and the risk of hypertension was analyzed using a Cox regression model. A total of 4424 (21.6%) of 20,190 subjects included had new-onset hypertension during a follow-up duration of 3.6 years. Compared with subjects with 0 points, the adjusted hazard ratios (95% confidence intervals) for the development of hypertension for those with 1, 2, 3, and ≥4 points were 1.21 (1.07-1.38), 1.34 (1.19-1.52), 1.44 (1.26-1.63), and 1.64 (1.44-1.87), respectively (P < 0.001), after adjustment for sex and baseline blood pressure. Age, resting heart rate, overweight/obesity, dyslipidemia, hyperuricemia, impaired glucose regulation, and a poor estimated glomerular filtration rate are associated with an increased risk of future hypertension. When these factors are combined, there is an accumulated increase in risk.

Entities:  

Mesh:

Year:  2019        PMID: 31431682     DOI: 10.1038/s41371-019-0232-9

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  3 in total

1.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Circulation       Date:  2018-10-23       Impact factor: 29.690

2.  [2010 Chinese guidelines for the management of hypertension].

Authors:  Li-Sheng Liu
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2011-07

3.  [Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population].

Authors:  Beifan Zhou
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2002-02
  3 in total
  3 in total

1.  Prevalence of Hypertension and 10-Year Cardiovascular Disease Risk Among Older Adults Living in Quanzhou, A Coastal Region of Southeast China.

Authors:  Huiqin Lin; Yuting Wu; Jinying Wu; Qiang Chen; Jun Yu; Yongjun Lin
Journal:  Risk Manag Healthc Policy       Date:  2022-05-13

2.  A longitudinal analysis of the progression from normal blood pressure to stage 2 hypertension: A 12-year Korean cohort.

Authors:  Eun Sun Yu; Kwan Hong; Byung Chul Chun
Journal:  BMC Public Health       Date:  2021-01-06       Impact factor: 3.295

3.  Association Between Heart Rate and Major Adverse Cardiovascular Events Among 9,991 Hypertentive Patients: A Multicenter Retrospective Follow-Up Study.

Authors:  Ningling Sun; Yuanyuan Chen; Yang Xi; Hongyi Wang; Luyan Wang
Journal:  Front Cardiovasc Med       Date:  2021-12-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.